Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
47 /100
MEDIUM RISK
Score updated Aug 28, 2026

BBLG — Bone Biologics Corporation Dilution Risk Tracker

Track BBLG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BBLG — Get alerts when the score changes →

As of August 28, 2026, Bone Biologics Corporation (BBLG) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Bone Biologics Corporation has a market capitalization of $2.37M, 2.76M shares outstanding, 3 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $1.06M, 75.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 20%
🔄 Reverse Split model est. 30%
• 50-day avg $1.26 approaching $1 threshold
💰 Capital Raise model 18%
• Active ATM program with $1M remaining capacity
🔔 Track BBLG — Get forecast alerts →

Market Data

Market Cap$2.37M
Shares Outstanding2.76M
Float1.79M
Cash$6.19M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↓ 91.4% shares (2026Q1 vs prior)
3 institutional holders · 4.4K shares
#1 Tower Research Capital LLC (TRC) 4.1K shares
#2 SBI Securities Co., Ltd. 230 shares
#3 UBS Group AG 56 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest21.0K
Days to Cover1.0
% of Float1.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2021-12-31
424B5 ATM 2026-03-13
8-K 8K EVENT 2026-03-13
4 INSIDER TRANSACTION 2026-01-21
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BBLG Dilution Snapshot

Bone Biologics Corporation (BBLG) has a DilutionScore of 47/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BBLG Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BBLG — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BBLG
BBLG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.